Predictors of Resectability and Survival in Patients with Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment with FOLFIRINOX

被引：5
作者：
Hu, Hai-Jie [1 ]
Li, Fu-Yu [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Biliary Surg, Chengdu, Sichuan, Peoples R China
来源：
ANNALS OF SURGERY | 2018年 / 268卷 / 06期
关键词：
D O I：
10.1097/SLA.0000000000002842
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：E95 / E96
页数：3
相关论文
共 8 条
[1]  
[Anonymous], 2017, ANN SURG
[2]   Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS) [J].
Bockhorn, Maximilian ;
Uzunoglu, Faik G. ;
Adham, Mustapha ;
Imrie, Clem ;
Milicevic, Miroslav ;
Sandberg, Aken A. ;
Asbun, Horacio J. ;
Bassi, Claudio ;
Buechler, Markus ;
Charnley, Richard M. ;
Conlon, Kevin ;
Cruz, Laureano Fernandez ;
Dervenis, Christos ;
Fingerhutt, Abe ;
Friess, Helmut ;
Gouma, Dirk J. ;
Hartwig, Werner ;
Lillemoe, Keith D. ;
Montorsi, Marco ;
Neoptolemos, John P. ;
Shrikhande, Shailesh V. ;
Takaori, Kyoichi ;
Traverso, William ;
Vashist, Yogesh K. ;
Vollmer, Charles ;
Yeo, Charles J. ;
Izbicki, Jakob R. .
SURGERY, 2014, 155 (06) :977-988
[3]   Preoperative Serum CA125 Levels Predict the Prognosis in Hyperbilirubinemia Patients With Resectable Pancreatic Ductal Adenocarcinoma [J].
Chen, Tao ;
Zhang, Min-Gui ;
Xu, Hua-Xiang ;
Wang, Wen-Quan ;
Liu, Liang ;
Yu, Xian-Jun .
MEDICINE, 2015, 94 (19)
[4]   FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer [J].
Conroy, Thierry ;
Desseigne, Francoise ;
Ychou, Marc ;
Bouche, Olivier ;
Guimbaud, Rosine ;
Becouarn, Yves ;
Adenis, Antoine ;
Raoul, Jean-Luc ;
Gourgou-Bourgade, Sophie ;
de la Fouchardiere, Christelle ;
Bennouna, Jaafar ;
Bachet, Jean-Baptiste ;
Khemissa-Akouz, Faiza ;
Pere-Verge, Denis ;
Delbaldo, Catherine ;
Assenat, Eric ;
Chauffert, Bruno ;
Michel, Pierre ;
Montoto-Grillot, Christine ;
Ducreux, Michel .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (19) :1817-1825
[5]   Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions [J].
Cwik, Grzegorz ;
Wallner, Grzegorz ;
Skoczylas, Tomasz ;
Ciechanski, Aleksander ;
Zinkiewicz, Krzysztof .
ARCHIVES OF SURGERY, 2006, 141 (10) :968-973
[6]   Prognostic Impact of Postoperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer [J].
Hata, Shojiro ;
Sakamoto, Yoshihiro ;
Yamamoto, Yusuke ;
Nara, Satoshi ;
Esaki, Minoru ;
Shimada, Kazuaki ;
Kosuge, Tomoo .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (02) :636-641
[7]   Management of pancreatic cancer in the elderly [J].
Higuera, Oliver ;
Ghanem, Ismael ;
Nasimi, Rula ;
Prieto, Isabel ;
Koren, Laura ;
Feliu, Jaime .
WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (02) :764-775
[8]   Vein Involvement During Pancreaticoduodenectomy: Is There a Need for Redefinition of "Borderline Resectable Disease"? [J].
Kelly, Kaitlyn J. ;
Winslow, Emily ;
Kooby, David ;
Lad, Neha L. ;
Parikh, Alexander A. ;
Scoggins, Charles R. ;
Ahmad, Syed ;
Martin, Robert C. ;
Maithel, Shishir K. ;
Kim, H. J. ;
Merchant, Nipun B. ;
Cho, Clifford S. ;
Weber, Sharon M. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2013, 17 (07) :1209-1217
1